Most Recent
Pepper spray class action claims Victoria police intended to injure protestors
Trials 2025-03-26 11:22 pm By Andy Sidler

Mid-trial amendments to a class action over Victoria Police use of pepper spray on environmental protesters in 2019 claim officers deployed the spray knowing and intending that it would harm the activists.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Lawyer accused of attempted blackmail wins round against Canberra firm
Business of Law 2025-03-25 4:10 pm By Christine Caulfield

A lawyer accused of trying to blackmail personal injury firm Maliganis Edwards Johnson has won a challenge to an injunction, with a judge finding the blackmail allegation was more nuanced than conveyed by the Canberra firm. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Chief of staff to Deputy PM Richard Marles drops bullying case
Employment 2025-03-25 11:11 pm By Christine Caulfield

A former chief of staff to Deputy Prime Minister Richard Marles has resolved her case alleging she was forced out after complaints of bullying.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘Egregious failure’ by lender’s counsel in appeal against ASIC win: court
Appeals 2025-03-24 4:44 pm By Cindy Cameronne

Payday lender Sunshine Loans has lost an appeal after it was ruled liable for “wrongheaded” conduct, with an appeals court finding that counsel showed an “egregious failure” to confine the case to the real issues. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

CIMIC class action funder asks court to rule on hypothetical commission
Class Actions 2025-03-24 11:09 pm By Andy Sidler

The funder that backed a shareholder class action against engineering firm CIMIC that settled for $45.25 million will take a cut to its 25 per cent commission, but wants the court to find the commission would otherwise have been reasonable. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Security contractors G4S, GEO targeted in cross-claim in detention class action
Class Actions 2025-03-24 4:59 pm By Cindy Cameronne

The federal government has launched a cross-claim against private security companies G4S and ACM in a class action on behalf of asylum seekers held in two immigration detention centres in South Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Construction PRO
Real estate group Coronis wins battle with ATO
Tax 2025-03-26 3:50 pm By Andy Sidler

Family-owned real estate group Coronis has successfully challenged the tax office on a $5 million alleged shortfall, with a judge finding service fees paid to two companies in the group were deductible.  

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Construction PRO
Brisbane Airport doesn’t have to follow AirServices’ ‘recipe’ for PFAS case: judge
Real Estate 2025-03-26 12:45 pm By Andy Sidler

A judge has refused a late-stage bid to strike out Brisbane Airport’s lawsuit against lessee AirServices Australia claiming $17.3 million in damage from PFAS contamination caused by its use of firefighting foam.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Construction PRO
United Petroleum wins lease dispute over ‘crater-size’ potholes
Construction 2025-03-26 1:25 pm By Julia Kanapathippillai

United Petroleum has successfully sued the landlords of one of its petrol stations for failing to pay for repairs to potholes described as “more like large craters”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis loses appeal over patent for heart drug Entresto
Intellectual Property 2025-03-24 11:50 pm By Cat Fredenburgh

Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis’ appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?